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a  b  s  t  r  a  c  t
Aims: To determine the appropriateness of the acute otitis media antibiotic treatment pre-
scribed in the community in relation to the therapeutic guidelines.
Methods: Children aged 3 months–3 years diagnosed with simple uncomplicated acute otitis
media in 6 community primary care clinics were enrolled. Data on the antibiotic treatment
were collected using computerized medical ﬁles.
Results: 689 simple uncomplicated acute otitis media patients were enrolled; 597 (86.9%)
were  treated with antibiotics by 38 family medicine practitioners, 12 pediatricians and 7
general practitioners. 461 (77.2%) patients were <2 years of age. Amoxicillin was adminis-
tered to 540 (90.5%) patients, with no differences between the various medical specialties.
127/540 (23.5%) patients did not receive the appropriate dosage; 140/413 (33.9%) patients
treated with appropriate dosage did not receive the treatment for the appropriate duration
of  time. 258/357 (72.3%) evaluable patients <2 years of age received an antibiotic consid-
ered inappropriate to guidelines (38 not treated with amoxicillin, 94 received inappropriate
dosage and 126 not treated for 10 days); 53/100 (53%) evaluable children >2 years of age
received an inappropriate antibiotic treatment.
Conclusions: The majority of primary care physicians treat simple uncomplicated acute otitismedia with the recommended antibiotic drug. However, incorrect dosage and shorter than
recommended duration of therapy may jeopardize the quality of care in children with simple
uncomplicated acute otitis media.
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The published guidelines for the treatment of AOM rec-
ommend an antibiotic treatment chosen according to the
suspected etiologic agent and its presumed susceptibility to
antibiotics.6–8 These guidelines were endorsed by Israel in
2006 and 2010,9,10 recommending amoxicillin as ﬁrst line
treatment for AOM, in a dosage of 80–90 mg/kg/day and for
a duration of 10 days in children <2 years of age and of 5–7
days in children >2 years of age without risk factors.7,8,11
When treatment failures occur, the second choice of antibi-
otics includes amoxicillin–clavulanate, cefuroxime axetil or
intramuscular ceftriaxone.
The objectives of this study were to analyze the adher-
ence to AOM treatment guidelines among primary health care
providers in southern Israel, with particular emphasis on the
prescribing patterns among various medical specialties and
on the adherence to guideline recommendation in respect to
the patient age.
Patients  and  methods
This was a descriptive prospective study, conducted from Jan-
uary 2003 through May 2004.
Setting
The study was conducted in six primary care pediatric clinics
of “Clalit” Health Care Services (CHS) in the city of Beer-Sheva,
southern Israel. CHS is the largest Health Maintenance Organi-
zation (HMO) in Israel, providing care to >50% of the population
in Israel. All clinics recorded patient data on a computerized
data system. All physicians participating in the study were
employees of CHS and were trained by CHS and also at the




Presence of acute symptoms and physical signs supporting
the diagnosis of AOM.
Simple  AOM  (s-AOM)
<3 AOM episodes during the last six months or <4 episodes
during last year and lack of antibiotic treatment for AOM or
any other disease during the 72-h period before enrollment.
Complicated  AOM
≥3 AOM episodes during the last six months or ≥4 episodes
during last year and/or administration of an antibiotic treat-
ment for AOM or any other disease during the 72-h period
before enrollment.Adequate  dosage
medication dosage ranging from −30% to +30% of the rec-
ommended dosage of amoxicillin (80 mg/kg/day) according to
guidelines.7,8 1 4;1  8(4):355–359
Under-dosage
<70% of the recommended dosage of amoxicillin according to
guidelines.
Appropriate  duration  of  therapy
10 days of treatment for children <2 years and 5–7 days for
patients >2 years.7,10,11
Adherence  to  therapy
Treatment course in which all three criteria (antibiotic
selected, adequate dosage and appropriate duration of ther-
apy) were met.
Non-adherence  to  therapy




All healthy infants and children living in the city of Beer Sheva
aged three months to three years who: (1) were diagnosed with
s-AOM by their primary care physicians in the clinics partic-
ipating in the study and (2) were treated with antibiotics by
their primary care physician.
Exclusion  criteria
Complicated AOM or any other ear disease.
Variables
Independent – demographic data such as age, gender, weigh,
physician specialty, antibiotics prescribed. Dependent – adher-
ence and non-adherence to the recommended guidelines.
Data  collection
Data were collected by the principal investigator (NS) and
research assistants by reviewing the computerized ﬁles sys-
tem of CHS. The principal investigator or research assistants
visited each clinic every 7–10 days and collected patient details
within up to 10 days from patient’s visit with an AOM diagno-
sis.
The following information was collected for all children
diagnosed with s-AOM:
a) Prescribed antibiotic selected, dosage and duration of ther-
apy.
b) Data on dosage were obtained either directly from the
medical ﬁle or indirectly calculated by using information
available on child’s weight and number of antibiotic bottles
prescribed.
(c) Treating physicians’ training/specialty status (pediatricianweight).
The study was approved by the Ethics Committee of Soroka
University Medical Center.
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Table 1 – Antibiotic prescribing patterns for s-AOM, according prescribing physician’s specialty.
Pediatrician
specialist (n = 8)
Resident
pediatrician
(n  = 4)
Family  medicine
physician (n = 38)
General
practitioner
(n  = 7)
No. patients (total = 597) 270 (45.2%) 122 (20.5%) 150 (25.1%) 55 (9.2%)
Antibiotics prescribed (n, %)
Amoxicillin (540, 90.5%) 237 (87.9) 113 (92.6) 140 (92.3) 50 (90.9)
Amoxicillin–clavulanate (29,
4.9%)
17 (6.5) 6 (4.9) 4 (2.7) 2 (3.6)
Azithromycin (14, 2.5%) 7 (2.7) 3 (2.5) 4 (2.7) –
Cefuroxime axetil (11, 1.9%) 7 (2.7) –  1 (0.7) 3  (5.5)
Other (3, 0.2%) 2  (0.2) –  1 (0.7) –
Duration of therapy (days) in patients treated with amoxicillina
1–5 9/237 (3.8) 13/113 (11.5) 1/140 (0.7) –
5–9 107/237 (45.1) 15/113 (13.3) 61/140 (43.6) 30/50 (60)
≥10 68/237 (28.7) 85/113 (75.2) 53/140 (37.9) 15/50 (30)
No data 53/237 (22.4) 25/140 (17.8) 5/50 (10)
Amoxicillin dosageb
Underdosage 38 (16)$,# 13 (11.5)$,# 49 (35)$ 27 (54)#
Adequate dosage 199 (84) 100 (88.5) 91 (65) 23 (46)
a Based on the information from the medical records and/or the number of bottles prescribed and/or dosage prescribed.































t$ p < 0.001 between pediatric specialists and residents, each versus fa
# p < 0.001 between pediatric specialists and residents, each versus g
ata  analysis
e  used the published guidelines as a reference basis to
nalyze adherence and non-adherence to recommended
reatment.6–9 Data were collected on an Excel electronic work-
heet and exported to analysis to SPSS software, version
5.0. A description of qualitative (patient: gender; physician:
pecialty and type of antibiotic treatment prescribed) and
uantitative (patient: age, duration of antibiotics treatment
rescribed and dosage) variables was performed. t-Test was
sed to compare continuous variables and chi-square test
or qualitative variables. Data were analyzed according to the
uidelines recommended for children under or above 2 years
f age.
esults
verall, 689 patients were diagnosed with s-AOM. Of them,
2 (13.3%) children were not treated with antibiotics; there-
ore, the study population included 597 (86.7%) children. These
atients were treated with antibiotics by 57 physicians: 38
66.7%) family medicine physicians, 12 (21%) pediatricians,
nd 7 (12.3%) general practitioners. Overall, 45.2% (270/597) of
he children were treated by a pediatrician. Four hundred and
ixty-one (77.2%) of the 597 children were <2 years of age. Five
undred and forty (90.4%) were treated with amoxicillin; of
hem 413 (69.1%) received an adequate dosage of the medica-
ion.
Table 1 describes the antibiotic prescribing characteristics
or s-AOM among four groups of prescribing physicians (family
edicine, pediatric specialists, pediatric residents and gen-
ral practitioners). There were no signiﬁcant differences in
he choice of antibiotic therapy among the four groups of physicians.
l practitioners.
physicians. In 31% (168/540) of the cases in which amoxicillin
was prescribed the duration of treatment recommended was
not mentioned (22.4%, 75.2%, 17.8% and 10% of the patients
treated by pediatricians, pediatric residents, family medicine
practitioners and general practitioners, respectively). Signif-
icantly more  patients treated by pediatric residents did not
have documentation of the duration of therapy in the medical
charts compared to each of the three other specialty cate-
gories (p < 0.01). More pediatricians (specialists or residents),
compared with general practitioners or family medicine prac-
titioners, prescribed the adequate antibiotic dosage as a
function of the child’s weight and according to the guidelines
(85.4% compared with 65% and 46%, respectively, p < 0.001).
Table 2 describes the characteristics of antibiotic prescrip-
tion as a function of patient age, drug dosage and duration
of therapy. Amoxicillin was the most frequently administered
antibiotic in both age groups (in 423 patients <2 years and 117
patients >2 years of age). The adequate dosage of amoxicillin
was prescribed in only 329 (77.8%) and 84 (71.8%) for the groups
of patients <2 years and >2 years old, respectively.
Duration of therapy was not mentioned in the medical
records of 104 patients <2 years of age and 36 patients >2 years
of age. While 44% (99/225) of the evaluable patients <2 years of
age received an appropriate duration of therapy (10 days), the
majority (97.9%, 47/48) of the patients >2 years of age received
an appropriate duration of therapy (>5 days for this age group).
In the group of children <2 years old and treated with an
adequate dosage of amoxicillin, 2.2% (5/225) of the patients
received treatment for 1–4 days only and 53.8% (121/225)
received treatment for 5–9 days only. In the group of children
>2 years old treated with an adequate dosage of amoxicillin,
2.1% (1/48) received treatment for 1–4 days only and 58.3%
(28/48) received treatment for 5–9 days, while 39.6% (19/48)
received treatment for 10 days.
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Table 2 – Amoxicillin prescription for AOM in the community by age groups, dosage and duration of therapy.
<2 years >2 years Total
No. patients 534 155 689
No. patients who received antibiotic treatment 461 (86.3%) 136 (87.7%) 597a (86.6%)
No. patients who received amoxicillin 423 (91.8%) 117 (86%) 540 (90.5%)
No. patients who received adequate dosage 329 (77.8%) 84 (71.8%) 413 (76.5%)
Duration of therapy
Adequate 99 (44%) 47 (97.9%) 146 (53.5%)
 (56%Inadequate 126
a 92 patients did not receive an antibiotic prescription for AOM.
Discussion
The objectives of this study were to analyze the adherence
to treatment guidelines of AOM among primary health care
providers in primary care health clinics in Southern Israel.
We chose to discuss only cases of simple uncomplicated
AOM, since the therapeutic decisions regarding cases of recur-
rent/persistent AOM are more  complicated and might be more
controversial in respect to diagnosis and treatment.
This study was conducted during 2003–2004, when clin-
ical guidelines regarding treatment of AOM, published by
various forums in USA, Europe and also in Israel were recom-
mending treating with antibiotics all children with AOM.7,8
This recommendation was and still is controversial, and in
several European countries, including the Netherlands, Bel-
gium and Scandinavian countries, avoiding treating AOM with
antibiotics immediately after diagnosis of the disease (in non-
toxemic children and without severe disease) was common
practice.9,10 Therefore, only 30–50% of the children with AOM
in these countries were treated with antibiotics, compared
to almost 90% in the USA, Canada, Australia and Israel. Dur-
ing recent years, a reassessment of the guidelines supporting
antibiotic administration immediately after diagnosis was
made in many  countries all over the world, mainly due to the
need of limiting antibiotics use and abuse in the treatment
of AOM and in order to reduce the high antibiotics resistance
rates among the main pathogens causing the disease.11 There-
fore, during that period, new guidelines for AOM treatment
were established by the American Academy for Pediatrics and
American Society of Family Medicine; in Israel, similar rec-
ommendations were released.12,13 These guidelines added the
recommendation of a 24–48 h period of “watchful waiting”
without administration of antibiotics in children >6 months
age without severe disease, assuming a clinical follow-up
could be conducted by the treating physician.
In the present study, we  showed that approximately 90%
of the physicians in six community clinics in Southern Israel,
regardless of their professional background, prescribed amox-
icillin as ﬁrst-line antibiotic treatment for AOM, in accordance
with the clinical guidelines published in Israel. This ﬁnding
reveals that most of these physicians were probably familiar
with the clinical guidelines regarding ﬁrst-line recommended
treatment. In contrast, amoxicillin was prescribed for 31–43%
of ﬁrst AOM episodes by medical professionals in the United
States.14,15
Only approximately 75% of the physicians participat-
ing in the present study prescribed an adequate dosage of) 1 (2.1%) 127 (46.5%)
amoxicillin. This ﬁnding is consistent with published data,
reporting that only 74% of the physicians in the United States
prescribe an antibiotic dosage consistent with the guidelines
recommendations.14
Signiﬁcantly more  pediatricians (specialists or residents),
compared to family medicine practitioners and general prac-
titioners, prescribed an adequate dosage of amoxicillin. This
ﬁnding is also consistent with published literature14 reporting
on superior adherence rate to guidelines among pediatricians
compared with general practitioners. This may suggest that
pediatricians may be more  accurate than family medicine
practitioners and general practitioners in dosing prescribed
drugs according to patient weight. Another possible explana-
tion for this discrepancy may be related to better and more
frequent training of pediatricians in southern Israel, con-
tributing to broader knowledge on the appropriate approach
to AOM treatment. According to literature reports, physicians’
training is helpful in improving knowledge and antibiotic use
patterns.15,16,17 Many  physicians participating in the present
study did not record in the patient medical charts the rec-
ommended duration for antibiotics use. On the other hand,
this information could have been conveyed verbally to par-
ents during the visit. Some of the physicians who  did not
record the recommended duration for antibiotics usage, did
prescribe the recommended number of bottles of antibiotics
needed; therefore the exact duration of treatment could be
ultimately calculated by the authors of the present study. In
any case, the fact that 33.9% of the patients treated with amox-
icillin (despite receiving an appropriate drug dosage) did not
receive treatment for the appropriate duration of therapy, is
of major concern.
In regard to appropriateness of treatment to guidelines
by age groups, we found that only approximately 25% of the
children <2 years of age were treated according to the guide-
lines in terms of the three main parameters investigated
(antibiotic type, dosage and treatment duration). This infor-
mation is complementary to and broadens recently published
data; Garbutt et al.16 reported that an appropriate duration
of therapy was prescribed in 98% of the children with AOM
receiving amoxicillin (without referral to appropriateness of
drug dosages).
It is interesting to point out that the duration of treatment
was more  adequately prescribed for children >2 years than for
children <2 years of age. This may be, most probably, a result
of the more  liberal recommendations for treatment duration
for children >2 years of age and leaving to discretion of the
treating physician the option to decide between 5 and 7 days
of treatment.6–9 In conclusion, we  showed that the majority
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f the primary care physicians treat s-AOM with the recom-
ended antibiotic drug (amoxicillin). However, inappropriate
rug dosage and duration of therapy may jeopardize the qual-
ty of care in children with s-AOM.
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